The MGC Pharmaceuticals (ASX:MXC) share price is on a roll today. Here's why

The MGC Pharmaceuticals (ASX: MXC) share price is up 3.4% after the company shared news of a $1 million order.

| More on:
Three pills with faces showing sad to happy, indicating a rising share price for an ASX pharmaceutical company

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The MGC Pharmaceuticals Ltd (ASX: MXC) share price is having a great day as the company shared news of a $1 million order.

At its intraday high, the MGC Pharmaceuticals share price was 6.7% higher than yesterday's close, but it's since retreated.

The company's share price is trading at 6.1 cents, a 3.39% gain, at the time of writing.

Let's take a closer look at the latest news from the phytocannabinoid- and plant-focused pharmaceutical company.

Million-dollar baby

MGC Pharmaceuticals' newest purchase order comes from a European producer and distributor, Swiss PharmaCan AG.

Swiss PharmaCan has ordered around €640,000 ($995,000) worth of the company's ArtemiC Rescue, a food supplement that contains 4 plant-based ingredients ­– artemisinin, curcumin, boswellia serrata, and vitamin C.

This is its second order for ArtemiC Rescue after the first helped boost MGC Pharmaceuticals' quarter-on-quarter growth to a record high.

MGC Pharmaceutical says it has the ability to produce commercial-scale batches of ArtemiC Rescue at its Slovenian facility. 

The company has an agreement with Swiss PharmaCan, under which the European company must order at least 40,000 united of ArtemiC Rescue per quarter. The order announced today has seen it meet its quota for the current quarter.

Commentary from management

MGC Pharmaceuticals' co-founder and managing director Roby Zomer commented on the purchase order, saying:

Receiving a second order on such a large scale from Swiss PharmaCan demonstrates the increasing demand for our product ArtemiC Rescue, and its associated benefits.

Our team in Slovenia has been working tirelessly to ramp up production to ensure rapid deployment of this order, and any subsequent orders that may be received.

MGC Pharmaceuticals share price snapshot

The MGC Pharmaceuticals share price is going gangbusters this year, up 205% year to date with today's gains included. It's also up 103% over the last 12 months.

The company has a market capitalisation of around $134 million, with approximately 2.2 billion shares outstanding.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned.

The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Why 4DMedical shares are jumping 14% today

4DMedical shares climb on a new CFO appointment as investors focus on US expansion and rising use of its lung…

Read more »

A business woman flexes her muscles overlooking a city scape below.
Healthcare Shares

Why I plan to buy this incredible ASX 200 stock in 2026

A 33% pullback has put Pro Medicus back in focus. Here’s why I’m preparing to buy its shares in 2026.

Read more »

research with microscope
Healthcare Shares

This ASX healthcare stock just changed its debt. Here's why it matters

Shares in Mesoblast edge higher after the company announces a major change to its debt and funding structure.

Read more »

stock growth chart
Healthcare Shares

Will CSL shares crash again in 2026?

CSL shares have fallen almost 40% in 2025. Investors are now asking if the worst is already behind the stock.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Here's the dividend forecast out to 2030 for Sigma shares

This business could pay healthy dividends in the coming years…

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Mayne Pharma signals short-term pain as it resets for growth

It has been a turbulent year for Mayne Pharma after the terminated takeover bid by US company Cosette Pharmaceuticals.

Read more »

A man packs up a box of belongings at his desk as he prepares to leave the office.
Healthcare Shares

Regis Healthcare shares down 2% as CEO resigns

Dr Mellors will step down as CEO after more than six years in the role.

Read more »

Beautiful young woman drinking fresh orange juice in kitchen.
Healthcare Shares

Telix shares storm higher on big US and China news

Let's see why this biotech is getting attention on Monday.

Read more »